TY - JOUR
T1 - Synoptic reporting of echocardiography in carcinoid heart disease (ENETS Carcinoid Heart Disease Task Force)
AU - the ENETS Carcinoid Heart Disease Task Force
AU - Hofland, Johannes
AU - Lamarca, Angela
AU - Steeds, Richard
AU - Toumpanakis, Christos
AU - Srirajaskanthan, Rajaventhan
AU - Riechelmann, Rachel
AU - Panzuto, Francesco
AU - Frilling, Andrea
AU - Denecke, Timm
AU - Christ, Emanuel
AU - Grozinsky-Glasberg, Simona
AU - Davar, Joseph
AU - K Clift, Ashley
AU - Geilvoet, Wanda
AU - Grande, Enrique
AU - Pape, Ulrich Frank
AU - Prasad, Vikas
AU - van Velthuysen, Marie Louise
AU - Walter, Thomas
AU - Welin, Staffan
N1 - Funding Information:
Dr Angela Lamarca is part funded by The Christie Charity. We thank Dr Wichor Bramer from the Erasmus MC Medical Library for developing and updating the search strategies. Other members of the ENETS Carcinoid Heart Disease Task Force include: Ashley K Clift, Department of Endocrine Surgery, Imperial College London, London, United Kingdom; Wanda Geilvoet, Department of Internal Medicine, Section of Endocrinology, ENETS Center of Excellence, Erasmus MC and Erasmus Cancer Institute, Rotterdam, The Netherlands; Enrique Grande, Medical Oncology Department, MD Anderson Cancer Center Madrid, Madrid. Spain. Louis de Mestier, Gastroenterology and Pancreatology, Hopital Beaujon, Clichy, France; Ulrich‐Frank Pape, Department of Internal Medicine and Gastroenterology, Asklepios Kliniken, Hamburg, Germany; Vikas Prasad, Department of Nuclear Medicine, University Hospital Ulm, Ulm, Germany; Marie‐Louise van Velthuysen, Department of Pathology, ENETS Center of Excellence, Erasmus MC, Rotterdam, The Netherlands; Thomas Walter, Medical Oncology Unit, Hospices Civils de Lyon, ENETS Center of Excellence, Lyon, France; and Staffan Welin, Endocrine Oncology, ENETS Center of Excellence, Department of Medical Science, University Hospital, Uppsala, Sweden.
Funding Information:
Dr Angela Lamarca is part funded by The Christie Charity. We thank Dr Wichor Bramer from the Erasmus MC Medical Library for developing and updating the search strategies. Other members of the ENETS Carcinoid Heart Disease Task Force include: Ashley K Clift, Department of Endocrine Surgery, Imperial College London, London, United Kingdom; Wanda Geilvoet, Department of Internal Medicine, Section of Endocrinology, ENETS Center of Excellence, Erasmus MC and Erasmus Cancer Institute, Rotterdam, The Netherlands; Enrique Grande, Medical Oncology Department, MD Anderson Cancer Center Madrid, Madrid. Spain. Louis de Mestier, Gastroenterology and Pancreatology, Hopital Beaujon, Clichy, France; Ulrich-Frank Pape, Department of Internal Medicine and Gastroenterology, Asklepios Kliniken, Hamburg, Germany; Vikas Prasad, Department of Nuclear Medicine, University Hospital Ulm, Ulm, Germany; Marie-Louise van Velthuysen, Department of Pathology, ENETS Center of Excellence, Erasmus MC, Rotterdam, The Netherlands; Thomas Walter, Medical Oncology Unit, Hospices Civils de Lyon, ENETS Center of Excellence, Lyon, France; and Staffan Welin, Endocrine Oncology, ENETS Center of Excellence, Department of Medical Science, University Hospital, Uppsala, Sweden.
Publisher Copyright:
© 2021 The Authors. Journal of Neuroendocrinology published by John Wiley & Sons Ltd on behalf of British Society for Neuroendocrinology.
PY - 2022/3
Y1 - 2022/3
N2 - Background: This European Neuroendocrine Tumor Society (ENETS) Expert Consensus document aims to provide practical guidance and standardization for echocardiography in the screening and follow-up of carcinoid heart disease (CHD) in patients with a neuroendocrine tumour (NET) and carcinoid syndrome. Methods: NET experts within the ENETS Carcinoid Heart Disease Task Force reviewed both general reporting guidelines and specialized scoring systems for transthoracic echocardiography (TTE) in CHD. Based on this review, a dedicated template report was designed by the multidisciplinary working group of cardiologists, oncologists, endocrinologists, gastroenterologists, surgeons and radiologists. Results: We propose a Synoptic Reporting of Echocardiography in Carcinoid Heart Disease which represents an agreed peer reviewed proforma to capture information at the time of referral and enable a detailed outcome of CHD assessment. This includes a systematic and detailed list of structures to evaluate data to capture at the time of reporting of TTE. Conclusions: Adherence to these reporting guidelines aims to promote homogeneous and detailed evaluation of CHD to secure accurate assessment and allow comparison of studies performed intra- and inter-individually. These guidelines could also facilitate CHD assessment as part of prospective clinical trials to enable standardization of the findings seen in response to therapy.
AB - Background: This European Neuroendocrine Tumor Society (ENETS) Expert Consensus document aims to provide practical guidance and standardization for echocardiography in the screening and follow-up of carcinoid heart disease (CHD) in patients with a neuroendocrine tumour (NET) and carcinoid syndrome. Methods: NET experts within the ENETS Carcinoid Heart Disease Task Force reviewed both general reporting guidelines and specialized scoring systems for transthoracic echocardiography (TTE) in CHD. Based on this review, a dedicated template report was designed by the multidisciplinary working group of cardiologists, oncologists, endocrinologists, gastroenterologists, surgeons and radiologists. Results: We propose a Synoptic Reporting of Echocardiography in Carcinoid Heart Disease which represents an agreed peer reviewed proforma to capture information at the time of referral and enable a detailed outcome of CHD assessment. This includes a systematic and detailed list of structures to evaluate data to capture at the time of reporting of TTE. Conclusions: Adherence to these reporting guidelines aims to promote homogeneous and detailed evaluation of CHD to secure accurate assessment and allow comparison of studies performed intra- and inter-individually. These guidelines could also facilitate CHD assessment as part of prospective clinical trials to enable standardization of the findings seen in response to therapy.
KW - carcinoid heart disease
KW - echocardiography
KW - neuroendocrine neoplasia
KW - synoptic reporting
UR - http://www.scopus.com/inward/record.url?scp=85127192966&partnerID=8YFLogxK
U2 - 10.1111/jne.13060
DO - 10.1111/jne.13060
M3 - Article
C2 - 34825753
AN - SCOPUS:85127192966
SN - 0953-8194
VL - 34
JO - Journal of Neuroendocrinology
JF - Journal of Neuroendocrinology
IS - 3
M1 - e13060
ER -